Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma Multiforme · Glioma, Malignant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Fusheng Liu, MD,PhD

    Study Director

    Beijing Tiantan Hospital